Interleukin-2 Confers Cardioprotection by Inhibiting Mitochondrial Permeability Transition Pore by Cao, CM et al.
Title Interleukin-2 Confers Cardioprotection by InhibitingMitochondrial Permeability Transition Pore
Author(s) Cao, CM; Chen, JZ; Xia, Q; Zhang, SZ; Lin, GH; Wong, TM
Citation
The 26th Annual International Conference of the IEEE
Engineering in Medicine and Biology Society Proceedings, San
Francisco, CA, USA, 1-5 September 2004, v. 2, p. 3618-3621
Issued Date 2004
URL http://hdl.handle.net/10722/46968
Rights Creative Commons: Attribution 3.0 Hong Kong License
  Abstract—In the present study, we determined whether 
interleukin-2 (IL-2) confers cardioprotection by inhibiting 
mitochondria permeability transition pore (MPTP) opening. In 
isolated rat hearts subject to 30 min ischemia and 120 min 
reperfusion (IR), IL-2 (50 U/ml) decreased the infarct size and 
LDH release, effects blocked by a selective kappa-opioid 
receptor antagonist, Nor-BNI (5 microM) or an opener of 
MPTP, atractyloside (Atr, 20 microM). In isolated ventricular 
myocytes subjected to anoxia and reoxygenation (AR), which 
reduced both the amplitude of the electrically induced [Ca2+]i 
transient and diastolic [Ca2+]i, IL-2 attenuated the AR-induced 
alterations and their effects were abolished by Atr. In addition, 
IL-2 attenuated the reduction in calcein fluorescence in 
myocytes subject to AR and reduced calcium-induced swelling 
in mitochondria of rat hearts subjected to IR, which were 
similar to effect of inhibitor of MPTP. The observations 
indicated that IL-2 confers cardioprotection by inhibiting the 
MPTP opening. 
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I.  INTRODUCTION 
 
 Ischemic preconditioning (IPC) is a phenomenon in 
which transient nonlethal period of ischemia increase the 
resistance to a subsequent prolonged ischemic period [1]. It 
has been demonstrated that Gi protein coupled receptors 
(GPCR) mediate cardioprotection of IPC [2]. Kappa opioid 
receptor (κ-OR) is one of these G-protein coupled receptors 
[3]. Recently it has been shown that interleukin-2 (IL-2), a 
member of cytokine family, reduced cardiac injury of the rat 
heart subject to myocardial ischemia and reperfusion and its 
effect was attenuated by blockade of κ-OR with Nor-BNI, a 
κ-OR antagonist, indicating that IL-2 confers 
cardioprotection via κ-OR [4]. 
 The mitochondria permeability transition pore (MPTP) 
is a multiprotein complex formed at the contact sites 
between the inner and outer mitochondrial membranes [5]. 
Opening of MPTP causes apoptosis/necrosis, which may 
eventually lead to cell death [6]. The MPTP has been shown 
to stay closed during ischemia and only open in the first few 
minutes of reperfusion [7]; the latter results in myocardial 
injury [8]. So inhibition of MPTP opening may be beneficial 
and in fact it was demonstrated that blockade of MPTP 
opening conferred cardioprotection of IPC [9]. It is therefore 
hypothesized that IL-2 may confer cardioprotection by 
inhibiting MPTP. 
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Therefore, the aim of this study was to determine the role of 
the MPTP in cardioprotection of IL-2. 
 
 
II.  METHODOLOGY 
 
 1) Isolated perfused heart preparation: Hearts from 
male Sprague-Dawley rats of 250-300 g body weight were 
excised rapidly and placed in ice-cold Krebs–Henseleit (K-
H) perfusion buffer before being mounted on a Langendorff 
apparatus for perfusion at 37°C with K-H buffer at a 
constant pressure (100 cm H2O). The buffer, that had the 
following composition (mM): NaCl 118.0, KCl 4.7, CaCl2 
1.25, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25.0 and glucose 
11.0, was equilibrated with 95% O2/5% CO2. For hearts 
subjected to regional ischemia, a silk suture was placed 
around the left coronary artery to form a snare. The coronary 
artery was occluded by pulling the snare to produce 
ischemia. Reperfusion was achieved by releasing the snare. 
 2) Measurement of the area of risk: For determination 
of infarct size in hearts subjected to regional ischemia, the 
coronary artery was re-occluded at the end of the 
reperfusion period and a solution with 2.5% Evans blue was 
perfused to delineate the area of risk. Hearts were then 
frozen and cut into slices, which were then incubated in a 
sodium phosphate buffer containing 1% w/v 2, 3, 5-
triphenyl-tetrazolium chloride (TTC) for 15 min to visualize 
the unstained infracted region. Infarct and risk zone areas 
were determined with planimetry by using a software 
Image/J from NIH and infarct was expressed as a percentage 
of the risk zone. 
 3) Determination of myocardial injury by lactate 
dehydrogenase efflux: The effluent from the isolated 
perfused heart was collected at 5 min of reperfusion and 
lactate dehydrogenase (LDH) was spectrophotometrically 
assayed using a kit purchased from Sigma Chemical Co. 
LDH activity was expressed as units per liter. 
 4) Preparation of isolated ventricular myocytes: 
Single ventricular myocytes were prepared from the heart of 
male Sprague-Dawley rats by enzymatic dissociation. Only 
rod-shaped cells with clear cross striations were used for 
experiments. 
 5) Intracellular calcium recording: Intracellular Ca2+ 
and its transient were determined by a spectrofluorometric 
method using the sensitive dye fura-2 as Ca2+ indicator. 
Fluorescence was measured on an Olympus inverted 
microscope equipped with a fluorometer system (T.I.L.L., 
Germany). The Ca2+-dependent signal of fura-2 was 
obtained by illuminating at 340 and 380 nm and recording 
the emitted light at 510 nm. The [Ca2+]i transient was 
induced by supra-threshold stimuli at 0.2 Hz delivered by a 
stimulator through two platinum field-stimulation electrodes 
in the bathing fluid. 
 6) Measurement of MPTP opening with calcein: To 
determine the opening of MPTP, calcein release from 
myocytes was measured. Cells were loaded with 1 
micro calcein? -AM for 20 min at room temperature, and the 
quenching of cytosolic and nuclear calcein was achieved by 
addition of 5 mM cobalt chloride (CoCl2) to the solution. 
Calcein fluorescence (excitation at 488 nm and emission at 
505 to 550 nm) were recorded with the fluorometer system. 
 7) Statistical analysis: Values presented here are 
means±standard error of means. Statistical comparisons 
were performed by One-way analysis of variance and 
Newman-Keuls test. Differences of p<0.05 are regarded as 
significant. 
 
 
III.  RESULTS 
 
A.  Effect of IL-2 on myocardial infarct induced by 
myocardial ischemia and reperfusion in the presence of a 
MPTP opener 
 
 An infarct size of 43.1±7.7% was induced by 30 min of 
ischemia and 120 min of reperfusion. The infarct size was 
significantly reduced when IL-2 at 50 U/ml was 
administered for two cycles of 5 min each interspersed with 
a 5 min of drug-free perfusion before ischemia (Fig. 1). 
Pretreatment of the heart with Atr (20 microM) blocked the 
effect of IL-2 on infarction. Pretreatment of the heart with 
50 U/ml IL-2 significantly reduced the release of LDH (Fig. 
1), which was blocked by Atr. 
 
B.  Effect of IL-2 on the changes of intracellular calcium of 
isolated ventricular myocytes induced by anoxia and re-
oxygenation in the presence of a MPTP opener 
 
 As shown in Fig. 2 the amplitude of the electrical 
stimulated [Ca2+]i transient was markedly reduced during 
anoxia and recovered slightly during re-oxygenation. On the 
other hand, the fluorescence of end-diastolic calcium level 
was increased during anoxia and increased further during re-
oxygenation. Pretreatment of the myocytes with IL-2 (50 
U/ml) attenuated the effects on [Ca2+]i transient and end-
diastolic [Ca2+]i induced by anoxia and re-oxygenation. The 
effect of both IL-2 were blocked by the κ-OR antagonist, 5 
microM Nor-BNI (Fig 2). When Atr (20 microM) was 
administered for 25 min before anoxia, effect of IL-2 on 
electrical stimulated [Ca2+]i transient and end-diastolic 
[Ca2+]i were abolished (Fig. 2). Inhibition of MPTP opening 
with CsA (0.2 microM) attenuated the alterations in [Ca2+]i 
induced by anoxia and re-oxygenation (Fig. 2). 
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Fig, 1.  Effect of interleukin 2 (IL-2, 50 U/ml) on myocardial 
infarct (upper) or LDH release (bottom) in the isolated perfused 
rat heart subject to ischemia of 30 min and reperfusion of 2 h and 
in the presence of atractyloside (Atr, 20 microM). Data were 
expressed as mean±SE. (n=10 in each group) 
** p<0.01 compared with IR group 
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Fig. 2  Effect of pretreatment of interleukin-2 (IL-2, 50 U/ml) on 
the amplitude of the electrically induced [Ca2+]i transient (upper) 
and end-diastolic [Ca2+]i level (bottom) in isolated ventricular 
myocytes subject to 5 min anoxia and 10 min re-oxygenation and 
in the presence or absence of Nor-BNI (5 microM). Data were 
expressed as mean±SE. (n=16 in each group) 
** p<0.01 compared with AR group 
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C.  Effect IL-2 on the fluorescence of calcein in the isolated 
ventricular myocyte subject to anoxia and re-oxygenation 
 
 Perfusion with K-H solution for 10 min decreased the 
calcein signal by 15% while anoxia and reperfusion 
decreased the calcein signal by 80%, indicating opening of 
MPTP. In the presence of CsA (0.2 microM), the reduction 
in calcein signal was only 27%, indicating a marked 
attenuation compared with the group subject to anoxia and 
re-oxygenation. 
 Pretreatment of the myocyte with IL-2 at 50 U/ml also 
attenuated the decrease of the calcein signal induced by AR 
(Fig. 3). After incubation the myocytes with Nor-BNI (5 
microM) for 10 min, the effect of IL-2 was attenuated. 
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Fig. 3.  Time effect of anoxia/re-oxygenation (AR), cyclosporine 
A (CsA, 0.2 microM), interleukin-2 (IL-2, 50 U/ml) on 
fluorescence of calcein in ventricular myocytes. For AR myocytes 
were subject to 5 min anoxia followed by 10 min re-oxygenation. 
CsA (0.2 microM), IL-2 (50 U/ml), or Nor-BNI (5 mM) were 
administered. Calcein signals were measured for 10 min during re-
oxygenation. Data were expressed as mean±SE. (n=15 in each 
group) 
** p<0.01 compared with control; ## P<0.01 compared with AR 
group; ∆ P<0.05 compared with IL-2 group. 
 
 
 
IV.  DISCUSSION 
 
 The main observation of the present study was that κ-
OR stimulation with IL-2 conferred cardioprotection, 
inhibited opening of the MPTP and attenuated alterations of 
[Ca2+]i, effects also produced by an inhibitor of the opening 
of MPTP, cyclosporin A. Opening of the MPTP with a pore 
opener reversed the effects. These are the first evidence that 
cardioprotection of κ-OR stimulation by IL-2 involves the 
inhibition of opening of MPTP. Since κ-OR has been shown 
to mediate cardioprotection of preconditioning with 
ischemic insults, the finding supports an important role of 
inhibition of MPTP in cardioprotection of ischemic 
preconditioning as shown previously [10]. 
 In the present study we observed that inhibition of 
opening of MPTP by IL-2 or by the inhibitor of MPTP, that 
conferred cardioprotection, also attenuated the [Ca2+]i 
overload particularly during reperfusion, a period when 
severe cardiac infarction and arrhythmia occur [11]. On the 
other hand, opening of MPTP that abolished 
cardioprotection of IL-2, also abolished the attenuating 
effect of IL-2 on [Ca2+]i overload. The observation is in 
agreement with the notion that [Ca2+]i overload leads to 
mitochondrial Ca2+ accumulation, which leads to opening of 
MPTP and cardiac injury/death [12]. 
 In addition to cardiac injury, we also observed that 
inhibition of opening of MPTP by IL-2 or CsA caused 
restoration of amplitude of the electrically induced [Ca2+]i 
transient reduced by ischemic insult and reperfusion while 
opening of MPTP abolished the beneficial effect of IL-2. 
Since the electrically induced [Ca2+]i transient represents 
influx of Ca2+ across the L-type Ca2+ channel and release of 
Ca2+ from the sarcoplasmic reticulum during excitation-
contraction coupling and is directly correlated to contraction, 
the observations indicate that inhibition of opening of MPTP 
restores the cardiac contractility by restoring the Ca2+ 
homeostasis, impaired by ischemia/reperfusion, which is in 
agreement with our present understanding. 
 
 
V.  CONCLUSION 
 
In conclusion, the present study has provided the first 
evidence that IL-2 confers cardioprotection by inhibiting the 
opening of MPTP. 
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